The spin-off of GSK and Pfizer joint venture Haleon comes ahead of its listing next month which could value it at around £40 billion.
June 08, 2022 at 05:24 AM
3 minute read
Reporter
A large group of top commercial law firms are advising on the spin-off of GSK and Pfizer’s consumer healthcare business, Haleon.
Pfiizer announced its decision to exit the joint venture and to sell its 32% stake following the announcement that Haleon is due to be listed on the stock market next month in a process likely to value it at around £40 billion.
Presented by BigVoodoo
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Celebrating achievement, excellence, and innovation in the legal profession in the UK.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
DEPUTY SOLICITOR GENERAL Position No: 125-31487 Salary Range: Commensurate with Experience Closing Date: July 31, 2024. Click...
McCarter & English, LLP is actively seeking a biotechnology patent associate or patent agent with an advanced degree in biology, biochem...
The University of New Mexico (UNM) (https://www.unm.edu/) is seeking nominations, inquiries, and applications for the position of General Co...
